Evidence-Based Medicine Guidelines
Antioxidant treatment for amyotrophic lateral sclerosis
Antioxidant treatment for amyotrophic lateral sclerosis is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
Citation
"Antioxidant Treatment for Amyotrophic Lateral Sclerosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455370/all/Antioxidant_treatment_for_amyotrophic_lateral_sclerosis.
Antioxidant treatment for amyotrophic lateral sclerosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455370/all/Antioxidant_treatment_for_amyotrophic_lateral_sclerosis. Accessed October 24, 2019.
Antioxidant treatment for amyotrophic lateral sclerosis. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/455370/all/Antioxidant_treatment_for_amyotrophic_lateral_sclerosis
Antioxidant Treatment for Amyotrophic Lateral Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 October 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455370/all/Antioxidant_treatment_for_amyotrophic_lateral_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antioxidant treatment for amyotrophic lateral sclerosis
ID - 455370
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455370/all/Antioxidant_treatment_for_amyotrophic_lateral_sclerosis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -